29 Results

People

  1. Getta
    Getta
  2. Tallman
    Tallman
  3. Devlin
    Devlin
  4. Giralt
    Giralt
  5. Levine
    Levine
  6. Arcila
    Arcila
  7. Famulare
    Famulare
  8. Rampal
    Rampal
  9. Schulman
    Schulman
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (29)
  2. Hematologic Malignancies, Division of (29)
  3. Sloan Kettering Institute Postdocs (29)
  4. Adult Leukemia (28)
  5. Center for Hematologic Malignancies (28)
  6. GSK Faculty (22)
  7. Executive Committee, Center for Hematologic Malignancies (21)
  8. Human Oncology and Pathogenesis Program (21)
  9. Biostatistics Service (15)
  10. Epidemiology and Biostatistics (15)
  1. "Bartlomiej Getta"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (11)
Groups
  1. Department of Medicine (29)
  2. Hematologic Malignancies, Division of (29)
  3. Sloan Kettering Institute Postdocs (29)
  4. Adult Leukemia (28)
  5. Center for Hematologic Malignancies (28)
  6. GSK Faculty (22)

More Groups

People
  1. Bartlomiej Getta (29)
  2. Martin Tallman (20)
  3. Ross Levine (17)
  4. Sean Devlin (15)
  5. Sergio Giralt (14)
  6. Mikhail Roshal (13)

More People

Years
  1. 2023 (1)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (7)
  5. 2017 (6)
  6. 2016 (6)

More Years

Publications
  1. Blood (16)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Haematologica (2)
  4. American Journal of Hematology (1)
  5. Best Practice and Research: Clinical Haematology (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Elsevier Inc. (4)
  3. Ferrata Storti Foundation (2)
  4. Elsevier Ltd (1)
  5. Elsevier Science, Inc. (1)
  6. John Wiley & Sons (1)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Prognostic impact of RAS-pathway mutations in patients with myelofibrosis
    Journal Article

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Puga, R. D.; de Melo Alves Paiva, R.; Arcila, M. E.; Hamerschlak, N.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
    Journal Article

    Xiao, W.; Bharadwaj, M.; Levine, M.; Farnhoud, N.; Pastore, F.; Getta, B. M.; Hultquist, A.; Famulare, C.; Medina, J. S.; Patel, M. A.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • PHF6 mutations define a subgroup of mixed phenotype acute leukemia with aberrant T-cell differentiation
    Meeting Abstract

    Lewis, N.; Pastore, F.; Kumar, P.; Getta, B.; Hultquist, A.; Shaffer, B.; Giralt, S.; Rampal, R.; Arcila, M.; Levine, R.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save